BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7073355)

  • 1. A clinicopathologic correlation of mammographic parenchymal patterns and associated risk factors for human mammary carcinoma.
    Bland KI; Kuhns JG; Buchanan JB; Dwyer PA; Heuser LF; O'Connor CA; Gray LA; Polk HC
    Ann Surg; 1982 May; 195(5):582-94. PubMed ID: 7073355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast.
    Arthur JE; Ellis IO; Flowers C; Roebuck E; Elston CW; Blamey RW
    Br J Radiol; 1990 Nov; 63(755):845-9. PubMed ID: 2252976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening.
    Kuhl CK; Keulers A; Strobel K; Schneider H; Gaisa N; Schrading S
    Breast Cancer Res; 2018 Feb; 20(1):13. PubMed ID: 29426360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic parenchymal patterns and risk of breast cancer in postmenopausal women.
    Horwitz RI; Lamas AM; Peck D
    Am J Med; 1984 Oct; 77(4):621-4. PubMed ID: 6486138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between mammographic and histological risk factors for breast cancer.
    Boyd NF; Jensen HM; Cooke G; Han HL
    J Natl Cancer Inst; 1992 Aug; 84(15):1170-9. PubMed ID: 1635085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically.
    Rubin E; Visscher DW; Alexander RW; Urist MM; Maddox WA
    Cancer; 1988 May; 61(10):2077-82. PubMed ID: 3359405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xerographic parenchymal patterns and breast cancer.
    Brebner DM; Epstein EE; Lange M
    S Afr Med J; 1978 Nov; 54(21):853-6. PubMed ID: 746397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographic parenchymal patterns.
    Bland KI; Buchanan JB; Weisberg BF; Hagan TA; Gray LA
    Cancer; 1980 Jun; 45(12):3027-33. PubMed ID: 6248185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic determinants of the mammographic parenchymal pattern. A population-based study within a mammographic screening program.
    Bergkvist L; Tabàr L; Bergström R; Adami HO
    Am J Epidemiol; 1987 Dec; 126(6):1075-81. PubMed ID: 3687919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selected prognostic variables for mammographic parenchymal patterns.
    Buchanan JB; Weisberg BF; Sandoz JP; Gray LA; Bland KI
    Cancer; 1981 May; 47(9):2135-7. PubMed ID: 7226106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features.
    Beute BJ; Kalisher L; Hutter RV
    AJR Am J Roentgenol; 1991 Aug; 157(2):257-65. PubMed ID: 1853802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of needle localization mammographically assisted biopsy of the breast.
    Senofsky GM; Davies RJ; Olson L; Skully P; Olshen R
    Surg Gynecol Obstet; 1990 Nov; 171(5):361-5. PubMed ID: 2237718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic features of the breast and breast cancer risk.
    Brisson J; Merletti F; Sadowsky NL; Twaddle JA; Morrison AS; Cole P
    Am J Epidemiol; 1982 Mar; 115(3):428-37. PubMed ID: 7064977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between mammographic parenchymal pattern classification and incidence of breast cancer.
    Threatt B; Norbeck JM; Ullman NS; Kummer R; Roselle P
    Cancer; 1980 May; 45(10):2550-6. PubMed ID: 7378990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
    Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
    AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopsy of the breast for mammographically detected lesions.
    Franceschi D; Crowe J; Zollinger R; Duchesneau R; Shenk R; Stefanek G; Shuck JM
    Surg Gynecol Obstet; 1990 Dec; 171(6):449-55. PubMed ID: 2244276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer prediction and the Wolfe classification of mammograms.
    Carlile T; Kopecky KJ; Thompson DJ; Whitehead JR; Gilbert FI; Present AJ; Threatt BA; Krook P; Hadaway E
    JAMA; 1985 Aug 23-30; 254(8):1050-3. PubMed ID: 4021043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tabár classification of mammographic parenchymal patterns.
    Gram IT; Funkhouser E; Tabár L
    Eur J Radiol; 1997 Feb; 24(2):131-6. PubMed ID: 9097055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.
    Riza E; dos Santos Silva I; De Stavola B; Bradlow HL; Sepkovic DW; Linos D; Linos A
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):627-34. PubMed ID: 11401912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.